Resilience is an ambitious bet to improve cancer treatment
How two French entrepreneurs are methodically deconstructing and reconstructing cancer treatment to improve its efficiency
Meet Resilience, a new startup that wants to help cancer treatment institutes as well as cancer patients at every step of the treatment journey. It’s an ambitious project founded by two well-known French entrepreneurs. They want to leverage their tech skills for this new healthcare startup.
Behind the scenes, there are two co-CEOs — Céline Lazorthes and Jonathan Benhamou. Nicolas Helleringer and Matthieu Pozza are the two remaining co-founders acting as CTO and CPO, respectively. Lazorthes previously co-founded Leetchi, the leading money pot company in France. She also started MangoPay, a marketplace payment solution, as a spinout company. Crédit Mutuel Arkéa acquired both companies.